الأربعاء 13 ربيع الأول 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
تحقق من أن الموقع يستخدم بروتوكول HTTPS
مسجل لدى هيئة الحكومة الرقمية برقم :
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| <p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p> | ApoPharma | Ongoing | Deferiprone | 3b | LA38-EXT | Aseer Central Hospital |
| Cholecalciferol supplementation in critically ill patients with severe vitamin D deficiency in intensive care unit – a randomized controlled trial | King Abdullah Medical City, Makkah | Ongoing | VITAMIN D3 (CHOLECALCIFEROL) | 3 | IRB#16-252, V2 | King Abdullah Medical City (Makkah) |
| A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell transplantation | Novartis | Ongoing | Ruxolitinib (INC424) (Jakavi) | 3 | CINC424C2301 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma | Archigen Biotech Limited | Ongoing | Rituximab/ SAIT101 | 3 | AGB 002 | Prince Sultan Military Medical City (Riyadh), King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam) |
| "A PHASE 2/3, MULTICENTER, MULTINATIONAL,OPEN-LABEL STUDY TO EVALUATE THE EFFICACY ANDSAFETY OF ALXN1101 IN NEONATES WITH MOLYBDENUMCOFACTOR DEFICIENCY (MOCD) TYPE A" | Alexion | Ongoing | ALXN1101( Cyclic pyranopterin monophosphate monohydrobromide dihydrate) | 2b | ALXN1101-MCD-202 | King Fahad Medical City (Riyadh) |
| A Phase 4, Double-Blind, Randomised, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of Adalimumab Used in Conjunction with Surgery in Subjects with Moderate to Severe Hidradenitis Suppurativa | AbbVie | Ongoing | Adalimumab | 4 | M15-574 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| AfME Registry on GastroIntestinal Stromal Tumors (GIST) – A Retrospective Patients’ Profile Description and Evaluation of the Use of Tyrosine Kinase Inhibitors | Africa Middle East Cancer Intergroup (AMCI) | Ongoing | - | 4 | WI210066 | King Fahad Medical City (Riyadh) |
| Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia | Janssen-Cilag International NV | Ongoing | canagliflozin | 4 | 28431754DI | Specialized Medical Center (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah), Dallah Hospital (Riyadh), Almana Hospital (Jubail), Almouasa Hospital (Qatif), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh), Saudi German Hospital (Jeddah) |
| Clinical Effectiveness and Cost Implications of Patients Switching from Oral Antipsychotics to Long‑Acting Injectable Antipsychotics in the Treatment of Schizophrenia | Janssen-Cilag International NV | Ongoing | Consta | 4 | RRA-19315 | Alamal Complex for mental health (Riyadh), King Fahad University Hospital (Al-Khobar) |
| The Impact of Tigecycline Use on Fibrinogen Level in Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Patients. A Randomized Controlled Study | King Faisal Specialist Hospital & Research Center | Ongoing | Tigecycline | 4 | RAC#216103 | King Faisal Specialist Hospital and Research Center (Riyadh) |
تاريخ آخر تحديث: 10/09/2026 بتمام الساعة 10:01 صباحا بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.